Day: June 26, 2024

PyroGenesis Provides Update Regarding Receipt of $4.1 Million Payment

Additional payments are expected to follow MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to provide additional information in response to investor questions regarding receipt of the CAD$4.1 million payment announced earlier today. As previously announced, PyroGenesis contracted with Drosrite International LLC, which was in turn contracted by Radian Oil and Gas Services Company for an order of seven (7) Drosrite™ aluminum dross recovery systems pursuant to a CAD$25 million contract. The...

Continue reading

Else Nutrition Announces US$2 Million Offering of Units Priced At-The-Market

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), the Plant-Based baby, toddler, and children nutrition company, today announced that it has entered into an agreement with a single, healthcare-focused institutional investor for the purchase and sale of 13,245,033 Units (the “Units”) of the Company (collectively, the “Offering”), which will be sold at an issue price of US$0.151 per Unit (the “Issue Price”), for aggregate gross proceeds of US$2 million. The Offering is scheduled to close on, or shortly after, June 28, 2024, and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the Toronto Stock Exchange. The Company plans to use the net proceeds...

Continue reading

Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone

Tokyo, Japan and Cambridge, UK, 27 June 2024 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera. Nxera and AbbVie entered into this multi-target collaboration in 2022 to leverage Nxera’s NxWave™ platform to discover, develop and commercialize new medicines targeting novel G protein-coupled receptor (GPCR) targets associated with neurological disease. Under the terms of the agreement, Nxera is eligible to receive up to US$40 million in near-term research milestones, as well as further potential option, development and commercial milestones totalling up to US$1.2 billion, plus tiered royalties on global sales. Stacey Southall, VP Platform...

Continue reading

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Company Announcement Approval based on results from Phase 1/2 EPCORE® NHL-1 study, which demonstrated durable, clinically meaningful treatment responses in patients with challenging-to-treat R/R FL EPKINLY offers an off-the-shelf, T-cell engaging treatment option that enables treatment across practice settings to address high clinical need EPKINLY is the first and only bispecific antibody approved in the U.S. to treat both relapsed or refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY® (epcoritamab-bysp) for the treatment of adults with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more...

Continue reading

Condor Initiates Multi-Well Workover Campaign in Uzbekistan

CALGARY, Alberta, June 26, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based energy transition company is pleased to announce the initiation of a multi-well workover campaign for the eight gas-condensate fields it operates in Uzbekistan (the “Project”). This initial workover campaign includes installing proven artificial lift equipment to yield higher gas flow rates and increase well uptime, perforating newly identified pay intervals, performing downhole stimulation treatments, and isolating identified water intervals. With over 100 wells associated with the Project, both existing and shut-in wells will continue to be evaluated for optimization opportunities. The Company has also started construction of the first in-line flow separation unit, which separates water from the gas...

Continue reading

NOVONIX Granted Patent for All-Dry, Zero-Waste Cathode Synthesis

BRISBANE, Australia, June 27, 2024 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, today announced it has been granted a patent for its proprietary all-dry, zero-waste cathode synthesis technology in Japan. This patent (Patent JP7504195) furthers NOVONIX’s position as a leading provider of innovative technologies serving the electric vehicle and energy storage sectors by utilizing its all-dry, zero-waste cathode processing to produce high-quality single-crystal NMC powders. The Company currently has 10 families of cathode process patent applications in various stages of examination across different jurisdictions. Dr. Chris Burns, CEO of NOVONIX, said, “NOVONIX’s cathode process is a groundbreaking innovation that offers a transformative...

Continue reading

Teck Named to 2024 Best 50 Corporate Citizens in Canada

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been named as one of Corporate Knights’ 2024 Best 50 Corporate Citizens in Canada. This marks the 18th consecutive year Teck has been named as one of the Best 50 companies by Corporate Knights. “As we responsibly produce essential metals needed for global development and the energy transition, our team is focused on caring for the people, communities and the environment where we operate,” said Jonathan Price, President and CEO. “Being named as one of the Best 50 Corporate Citizens in Canada is a reflection of the commitment of our people, who prioritize environmental and social responsibility in everything they do.” The Best 50 Corporate Citizens in Canada are each evaluated on a set of up...

Continue reading

Clairvest Reports Fiscal 2024 Fourth Quarter and Year End Results

TORONTO, June 26, 2024 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fourth quarter and year ended March 31, 2024 and events which occurred subsequent to year end. (All figures are in Canadian dollars unless otherwise stated) Highlights March 31, 2024 book value was $1,176.3 million or $80.16 per share compared with $1,150.3 million or $78.38 per share as at December 31, 2023 and $1,217.7 million or $81.05 per share as at March 31, 2023 Net income for the fourth quarter was $26.1 million or $1.78 per share as the fair value of certain investments increased Net loss for fiscal 2024 was $3.4 million or $0.23 per share. During fiscal 2024, Clairvest had $38 million of net realized gains and $84 million of net unrealized losses on its private equity portfolio Clairvest commenced the investment program...

Continue reading

NOVAGOLD Reports Second Quarter 2024 Financial Results

Determined to Advance Donlin Gold to an Updated Feasibility Decision Unlocking Value Through Ongoing Technical Work, Comprehensive Engagement and Proactive Social Outreach Efforts Robust Treasury of $113 Million in Cash and Term Deposits VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) today released its 2024 second quarter financial results and an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”). Details of the financial results for the quarter ended May 31, 2024, are presented in the consolidated financial statements and quarterly report filed on Form 10-Q on June 26, 2024, that is available on the Company’s website at www.novagold.com, on SEDAR+ at www.sedarplus.ca,...

Continue reading

CPS Announces $436.31 Million Senior Subordinate Asset-Backed Securitization

LAS VEGAS, Nevada, June 26, 2024 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) announced the closing of its third term securitization in 2024 on Wednesday June 26, 2024. The transaction is CPS’s 52nd senior subordinate securitization since the beginning of 2011 and the 35th consecutive securitization to receive a triple “A” rating from at least two rating agencies on the senior class of notes. In the transaction, qualified institutional buyers purchased $436.31 million of asset-backed notes secured by $460.00 million in automobile receivables originated by CPS.   The sold notes, issued by CPS Auto Receivables Trust 2024-C, consist of five classes. Ratings of the notes were provided by Standard & Poor’s and DBRS Morningstar, and were based on the structure of the transaction,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.